Trial Condition(s):

Atrial Fibrillation

Atrial fibrillation screening with a smartphone device and iECG application (AFScreenCol)

Bayer Identifier:

18250

ClinicalTrials.gov Identifier:

NCT02534532

EudraCT Number:

Not Available

Terminated/Withdrawn

Trial Purpose

Question: Can atrial fibrillation (AF) cases in patients ≥ 65 years be easily detected in a primary healthcare
environment using a smartphone device and iECG application as an opportunistic screening tool?
Objectives:
Detection of AF through cardiac rhythm abnormalities in patients ≥65 years old in an opportunistic screening
program using a smartphone device/application
1. Define the predictable value of the smartphone device
with electrocardiogram (ECG) confirmation to detect AF
in patients 65 years and older
2. Correlate screened patients cardiovascular risk profile
and those that register cardiac rhythm irregularities for a
better description of the general characteristics of
Colombian population

Inclusion Criteria
- Females and males patients ≥65 years old attending primary care counselling
                - Written informed consent
Exclusion Criteria
- Patients with confirmed diagnosis of AF 
                - Patients who do not want to participate 
                - Patients consulting for acute conditions 
                - Patients presenting any diagnosed arrhythmia different than AF

Trial Summary

Enrollment Goal
0
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
No Drug
Accepts Healthy Volunteers
Yes

Where to Participate

Locations
Status
LocationsStatus

Trial Design